Articles

TransPharma Medical, Ltd., announced the successful completion of a Phase 1a trial of ViaDerm-GLP1 agonist which is being developed for the treatment of Type 2 diabetes….

Patients with mild to moderate heart failure who received educational materials and self-management counseling in an attempt to improve adherence to medical advice did not have a reduced rate of death or hospitalization compared to patients who received educational materials alone, according to a study….

A three-year lifestyle intervention resulted in sustained improvements in quality of life compared with the usual care in patients with moderate-to-high cardiovascular risk — also lessening risk factors and some overall healthcare costs, researchers found….

Patients with early-stage nonischemic cardiomyopathy derived significant functional and echocardiographic benefits from the addition of omega-3 fatty acids to optimized medical therapy, results of a randomized clinical trial showed….

A new focus on the immune system’s ability to both unleash and restrain its attack on disease has led scientists to identify cells in mice that prevent the immune system from attacking the animals’ own cells, protecting them from autoimmune diseases such as multiple sclerosis, Type 1 diabetes, and lupus….

The cost watchdog for Britain’s publicly-funded National Health Service has recommended daily use of Novo Nordisk A/S’s (NOVO-B.KO) product Victoza for some people with Type 2 diabetes, but only at a daily dosage of 1.2 milligrams….

Amyloid could “directly poison” pancreas cells. Shedding light on how a malfunctioning protein helps trigger Type 2 diabetes could one day offer the chance to halt the damage, say scientists…. 

VeroScience announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manufacture and commercialize Cycloset®, which has been approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes both as mono-therapy and in …

Urban air pollution — especially the particles and gases spewed by heavy traffic — can increase a person’s risk of developing Type 2 diabetes according to a new German study. People with chronic inflammation may be especially vulnerable…

More evidence for dentists being part of the diabetes team: cardiologists and other physicians who manage patients with CVD should collaborate with dentists to moderate cardiovascular risk in patients who also suffer from periodontitis…